upper respiratory tract infection
Conditions
Interventions
Experimental group:Fengreqing oral liquid
Control group:Yinhuang oral liquid
Sponsors
The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Comply with the diagnostic criteria of western medicine for acute upper respiratory tract infection; 2. Conform to the syndrome differentiation standard of exogenous wind-heat syndrome in traditional Chinese medicine; 3. Aged 18-75 years; 4. Pharyngeal pain VAS >= 4 points; 5. Agree and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with complications such as sinusitis, acute bronchitis and pneumonia; 2. Associated with the following serious lung diseases (such as asthma, chronic bronchitis, tuberculosis, etc.), primary cardiovascular disease, liver disease, kidney disease, hematological disease, or other serious diseases that affect their survival; 3. Allergic constitution (those who are allergic to more than 2 substances), or those who are allergic to the components of this preparation and the control drug; 4. Patients who are pregnant, planning to become pregnant or breastfeeding; 5. Those who have participated in other clinical trials in the past month; 6. The patient is unable to cooperate or is mentally ill, and the researcher considers it inappropriate to participate in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recovery rate;Pharyngeal pain disappearance rate; | — |
Countries
China
Contacts
Public ContactFeng Jihong
The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Outcome results
None listed